WE MAKE AQUACULTURE PROGRESS
- An important step for sustainable aquaculture in Vietnam
• ALPHA JECT ® Panga 2 has been approved by the Department of Animal Health and will be available for customers in Vietnam early 2017
• The vaccine protects against Edwardsiella ictaluri and Aeromonas hydrophila, bacterias causing significant losses in the Vietnamese pangasius industry
PHARMAQ and Zoetis leaders came together in Puerto Montt, Chile last week to celebrate and promote the launch of ALPHA JECT LiVac® SRS, an innovative vaccine that helps control Salmon Rickettsial Septicaemia (SRS) Syndrome.
Zoetis Completes Purchase of PHARMAQ, the Global Leader in Vaccines and Innovation for Health Products in Aquaculture
FLORHAM PARK, N.J. - November 10, 2015 - Zoetis Inc. (NYSE:ZTS) today announced that it has completed the purchase of PHARMAQ, the global leader in vaccines and innovation for health products in aquaculture, for a price of $765 million on a debt-free basis, having fulfilled all closing requirements.
Did you know...
Newsfeed delivered by Meltwater News. PHARMAQ is not to be held liable for any of its content nor possible incorrect information given.
“Queremos reducir riesgos biológicos y mejorar la sustentabilidad en salmonicultura”
Asia-Pacific Animal Health Market worth USD 20.25 Billion by 2021
ZOETIS ANNOUNCES THEIR ACQUISITION OF FISH VET GROUP
Benchmark extends Chilean salmon farming focus, completes sale of Zoetis
Benchmark Holdings secures sale of veterinary business
Zoetis adquiere Fish Vet Group de Benchmark
Ny forskning på Pasteurellose hos rognkjeks og laks - Kyst.no
Benchmark completes sale of FishVet subsidiary - Business Link Magazine